MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹7,420 Cr | ₹187 Cr | ₹199 Cr | ₹169 Cr | ₹107 Cr |
What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹7,420 Cr |
| Mar2024 | ₹187 Cr |
| Mar2023 | ₹199 Cr |
| Mar2022 | ₹169 Cr |
| Mar2021 | ₹107 Cr |
How is Total Non-Current Liabilities of MANKIND PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,420 Cr | 3,860.66 | |
| Mar2024 | ₹187 Cr | -5.97 | |
| Mar2023 | ₹199 Cr | 18.12 | |
| Mar2022 | ₹169 Cr | 57.15 | |
| Mar2021 | ₹107 Cr | - | |
Compare Total Non-Current Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,591.0 Cr | -0.1% | -8.3% | -14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.1% |
-8.3% |
-14% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses